Roles of N6-Methyladenosine (m6A) in Stem Cell Fate Decisions and Early Embryonic Development in Mammals

被引:61
|
作者
Zhang, Meng [1 ]
Zhai, Yanhui [1 ]
Zhang, Sheng [1 ]
Dai, Xiangpeng [1 ]
Li, Ziyi [1 ]
机构
[1] First Hosp Jilin Univ, Key Lab Organ Regenerat & Transplantat, Minist Educ, Changchun, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
N6-methyladenosine; RNA metabolism; stem cell fate; cell reprogramming; embryonic development; MESSENGER-RNA METHYLATION; NUCLEAR-RNA; REGULATES PLURIPOTENCY; HEMATOPOIETIC STEM; READER YTHDF2; N-6-METHYLADENOSINE; DIFFERENTIATION; TRANSLATION; REVEALS; PROTEIN;
D O I
10.3389/fcell.2020.00782
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
N6-methyladenosine (m(6)A) is one of the most abundant internal mRNA modifications, and it affects multiple biological processes related to eukaryotic mRNA. The majority of m(6)A sites are located in stop codons and 3 ' UTR regions of mRNAs. m(6)A regulates RNA metabolism, including alternative splicing (AS), alternative polyadenylation (APA), mRNA export, decay, stabilization, and translation. The m(6)A metabolic pathway is regulated by a series of m(6)A writers, erasers and readers. Recent studies indicate that m(6)A is essential for the regulation of gene expression, tumor formation, stem cell fate, gametogenesis, and animal development. In this systematic review, we summarized the recent advances in newly identified m(6)A effectors and the effects of m(6)A on RNA metabolism. Subsequently, we reviewed the functional roles of RNA m(6)A modification in diverse cellular bioprocesses, such as stem cell fate decisions, cell reprogramming and early embryonic development, and we discussed the potential of m(6)A modification to be applied to regenerative medicine, disease treatment, organ transplantation, and animal reproduction.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Impact of N6-methyladenosine (m6A) modification on immunity
    Elsabbagh, Raghda A.
    Rady, Mona
    Watzl, Carsten
    Abou-Aisha, Khaled
    Gad, Mohamed Z.
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [22] Advances in the profiling of N6-methyladenosine (m6A) modifications
    Zheng, Hong-xiang
    Zhang, Xian-sheng
    Sui, Na
    BIOTECHNOLOGY ADVANCES, 2020, 45
  • [23] The role of N6-methyladenosine (m6A) in eye diseases
    Gao, Jing-Fan
    Zhang, Lu
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (08) : 6145 - 6150
  • [24] Impact of N6-methyladenosine (m6A) modification on immunity
    Raghda A. Elsabbagh
    Mona Rady
    Carsten Watzl
    Khaled Abou-Aisha
    Mohamed Z. Gad
    Cell Communication and Signaling, 20
  • [25] The role of N6-methyladenosine (m6A) in eye diseases
    Jing-Fan Gao
    Lu Zhang
    Molecular Biology Reports, 2021, 48 : 6145 - 6150
  • [26] N6-methyladenosine (m6A) modification in hepatocellular carcinoma
    Ma, Hehua
    Hong, Yuxin
    Xu, Zhenzhen
    Weng, Zuyi
    Yang, Yuanxun
    Jin, Dandan
    Chen, Zhiyou
    Yue, Jing
    Zhou, Xuan
    Xu, Zhi
    Fei, Fei
    Li, Juan
    Song, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [27] N6-methyladenosine (m6A) modification in gynecological malignancies
    Zhang, Chunmei
    Liu, Ning
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (09) : 3465 - 3479
  • [28] The role of N6-methyladenosine (m6A) in kidney diseases
    You, Luling
    Han, Zhongyu
    Chen, Haoran
    Chen, Liuyan
    Lin, Yumeng
    Wang, Binjian
    Fan, Yiyue
    Zhang, Meiqi
    Luo, Ji
    Peng, Fang
    Ma, Yue
    Wang, Yanmei
    Yuan, Lan
    Han, Zhongyu
    FRONTIERS IN MEDICINE, 2023, 10
  • [29] N6-methyladenosine (m6A) depletion regulates pluripotency exit by activating signaling pathways in embryonic stem cells
    Jin, Kang-Xuan
    Zuo, Rujuan
    Anastassiadis, Konstantinos
    Klungland, Arne
    Marr, Carsten
    Filipczyk, Adam
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (51)
  • [30] Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
    Jiahua Chen
    Bao Guo
    Xiaojing Liu
    Jing Zhang
    Junhui Zhang
    Yuan Fang
    Suding Zhu
    Bing Wei
    Yunxia Cao
    Lei Zhan
    Experimental Hematology & Oncology, 11